PPV without ILM peeling favourable for ODP

Article

Pars plana vitrectomy, endolaser photocoagulation and C3F8 gas tamponade without internal limiting membrane (ILM) peeling have been found to be potentially favourable in the treatment of optic disc pit (ODP) maculopathy, according to data published in Eye.

Pars plana vitrectomy, endolaser photocoagulation and C3F8 gas tamponade without internal limiting membrane (ILM) peeling have been found to be potentially favourable in the treatment of optic disc pit (ODP) maculopathy, according to data published in Eye.

Dr R. Avci et al. (Retina Eye Hospital, Bursa, Turkey) examined 13 eyes from 12 patients undergoing surgery to treat serous macular detatchment and/or macular retinoschisis secondary to congenital ODP. All patients included in the study were treated with PPV, posterior hyaloid removal, endolaser photocoagulation on the temporal margin of the optic disc and 12% C3F8 gas tamponade.

The team used optical coherence tomography (OCT) to analyse the anatomic success and functional outcome of surgery and they measured the patients’ best-corrected visual acuity (BCVA) as well. The majority of the study group experienced an improvement in BCVA of 2 lines or more and 12 eyes experienced complete reabsorption or subretinal and intraretinal fluid.

These results indicated that PPV, C3F8 gas tamponade and endolaser to the optic disc margin without ILM peeling could be a beneficial surgical option for patients suffering with ODP maculopathy and earlier surgical intervention leads to better visual improvements.

For further information please view the abstract here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.